Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Change in Taxes: 2018-2020

Historic Change in Taxes for Silence Therapeutics (SLN) over the last 3 years, with Dec 2020 value amounting to $4.5 million.

  • Silence Therapeutics' Change in Taxes rose 33.85% to $4.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.4 million, marking a year-over-year increase of 6.68%. This contributed to the annual value of $4.5 million for FY2020, which is 6.87% up from last year.
  • Per Silence Therapeutics' latest filing, its Change in Taxes stood at $4.5 million for FY2020, which was up 6.87% from $4.2 million recorded in FY2019.
  • In the past 5 years, Silence Therapeutics' Change in Taxes registered a high of $4.5 million during FY2020, and its lowest value of $2.8 million during FY2018.
  • In the last 3 years, Silence Therapeutics' Change in Taxes had a median value of $4.2 million in 2019 and averaged $3.8 million.
  • Data for Silence Therapeutics' Change in Taxes shows a peak YoY soared of 48.63% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Silence Therapeutics' Change in Taxes stood at $2.8 million in 2018, then soared by 48.63% to $4.2 million in 2019, then grew by 6.87% to $4.5 million in 2020.